Page last updated: 2024-10-24

camostat and Cholelithiasis

camostat has been researched along with Cholelithiasis in 2 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimoda, I2
Ishizuka, H1
Murakami, M1
Sato, K2
Hirano, H2
Tanno, N2
Ohira, C1
Koizumi, M2
Toyota, T2
Ishizuka, J1

Other Studies

2 other studies available for camostat and Cholelithiasis

ArticleYear
[A new experimental trial for dissolution of gallbladder stones].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1989, Volume: 86, Issue:10

    Topics: Animals; Cholelithiasis; Cholesterol; Cricetinae; Deoxycholic Acid; Drug Therapy, Combination; Ester

1989
Combination therapy of trypsin inhibitor with ursodeoxycholic acid on cholesterol gallbladder stone.
    Gastroenterologia Japonica, 1989, Volume: 24, Issue:3

    Topics: Cholelithiasis; Cholesterol; Deoxycholic Acid; Drug Therapy, Combination; Esters; Gabexate; Guanidin

1989